💹 Your Post-Notable Earnings Report (Aug 15)

Open Email...Your Morning Report Inside…Post Earnings for Major Stocks
Your Notable Earnings Report

Unsubscribe

⭐⭐ [Recommended] Buy on Friday, cash out on Monday…💰 🤑 (ad)
Dear Reader,
I hope you are having a great Friday and also hope you have a good weekend ahead of you! I am sending you the list of major stocks which reported Earnings a few days ago with Earnings Surprise (to help you find Post-Earnings trading and/or investing opportunities).

Cancer Immunotherapy Play Adds $500M Twist (ad)**
A biotech targeting safer, more effective immune-oncology treatments is considering a $500M capital arm to fuel growth without heavy dilution. Two high-growth markets, one low-float setup.
👉 Click to see why this is on watch.

Symbol CompanyEarning DateEPS Surprise %
VIPS08/14 before -16.33%
CODX08/14 before 8.00%
TPR08/14 before 2.97%
WB08/14 before %
AG08/14 before -33.33%
JD08/14 before 25.00%
NTES08/14 before 1.08%
DE08/14 before 2.81%
SAVA08/14 before %
BTBT08/14 before 0.00%
GWH08/14 After -2.27%
TMC08/14 After -16.67%
AMAT08/14 After 5.98%
SSYS08/13 before 33.33%
SPWR08/13 before %
Click Here to View Your Full Report
sun Before Market Opensun After Market Close

Two Markets. 🎯 One Low-Float Opportunity. (ad)**
A biotech with a safer cancer therapy approach and a military-linked artificial blood project is eyeing a $500M non-dilutive funding vehicle.
>>> Here's why this combination has traders circling.

Palantir's Stock Is Climbing and So Is Their New Partner's (ad)*
It's a model built to scale. And it's live right now. This is not a crowded trade. It's still under the radar. But not for long. The AI arms race is heating up. And this partnership could signal a breakout moment.
See what Palantir saw. Learn more and unlock the symbol here by subscribing. (Click to Opt-in)

How to use EPS Surprice in your Post-Earnings trading strategies:
Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's earnings announcement) or the Price Reversal strategy (to target the reversal of next-day big price movement). Please click on Ride-the-Wave Strategy to learn more about it.
Stock Trading - If you're a stock trader/investor or portfolio manager, you may want to consider adjusting your positiosn based on a EPS surprise reported by the company.
At Daily Options Signals, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader.
To your trading success,
Support Team
Daily Options Signals
PS: Daily Options Signals is morning newsletter, powered by StockEarnings proprietary technology.
URGENT: Trump's AI Policy Shift
Massive manufacturing reshoring is coming
FREE report just released → Get your copy before it's too late

(ad)* This message is a PAID ADVERTISEMENT for Knightscope, Inc (NASDAQ:KSCP) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $10,000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between August 1, 2025 and August 31, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Knightscope, Inc (NASDAQ:KSCP) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Knightscope, Inc (NASDAQ:KSCP) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Knightscope, Inc (NASDAQ:KSCP).

(ad)** This message is a PAID ADVERTISEMENT for Liminatus Pharma Inc (NASDAQ:LIMN) from Market Jar Media Inc. StockEarnings, Inc. has received a fixed fee of $25000 from Market Jar Media Inc for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between August 14, 2025 and August 21, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Liminatus Pharma Inc (NASDAQ:LIMN) or Market Jar Media Inc. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Liminatus Pharma Inc (NASDAQ:LIMN) on TradingWhisperer website for additional information about the relationship between Market Jar Media Inc and Liminatus Pharma Inc (NASDAQ:LIMN).

Daily Options Signals is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities.

This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised.

All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers.

StockEarnings Inc

33 SE 4th St, Suite 100,

Boca Raton, FL 33432 USA | W: 877.6.STOCKS

Unsubscribe


Today's Bonus Content: Palantir's Stock Is Climbing and So Is Their New Partner's (ad)*

Post a Comment

Previous Post Next Post

Contact Form